|
Editorial Note
Kaushik Banerjee announces publication of a new journal supplement titled: The fallacy of coverage: uncovering disparities and improving immunization coverage.
Get an update on shortage of essential vaccines in India from Omesh Bharti, who also posts on the number of vaccines that can be given intradermally.
Integration of the immunization supply chain with supply chains of other health products—Ranjit Dhiman responds to Modibko Dicko's post on the subject.
|
|
 |
|
|
|
|
|
This is to announce the publication of a journal supplement titled The fallacy of coverage: uncovering disparities and improving immunization coverage - The Canadian International Immunization Initiative Phase 2 (CIII2).
The supplement, which contains 13 research articles, one introduction and one opinion piece, is being published by BioMed Central's Journal of International Health and Human Rights.
The articles present the results of a multi-country research project and explain why some children in developing countries are not receiving vaccines. The research also shows how targeted, low-cost interventions can increase
vaccination rates, at times doubling or tripling the odds of children being
vaccinated.
[Read more]
Comment on this post by email or on the web |
|
|
|
|
|
|
Information gathered from the Health Ministry through the Right to Information (RTI) Act confirms the overall shortage of 17 crore doses for diphtheria, measles, tetanus and oral polio vaccine.
The shortage for diphtheria vaccine is nine crore doses, followed by 3.14 crore for tetanus, three crore for oral polio vaccine and 90 lakh for measles. The total procurement of vaccines has fallen from 64.10 crore to 58.32 crore this year. The situation, which was already bad last year with an overall shortage of 14.5 per cent, has worsened this year with a shortfall between requirement and procurement resting at 22 per cent.
[Read more]
Comment on this post by email or on the web |
|
|
|
|
|
|
Here is more on intradermal delivery of vaccines. As many as 10 vaccines can be given intradermally to spare costs as well as doses, but unfortunately this is not promoted by vested interests. Please see the link on the WHO website ...
[Read more]
Comment on this post by email or on the web |
|
|
|
|
|
|
Though the cold chain is a vertical system in India, despite massive efforts from MOH and partner agencies, the quality of services is directly linked to performance of the staff handling (the) cold chain and not only to the systems in place. There are shortages of cold chain equipment every year; massive procurement of ILR/DFs/cold rooms is happening; and there are new challenges of creating infrastructure. Cost optimization becomes secondary, with the primary focus on managing supplies and ensuring that the cold chain is maintained.
[Read more]
Comment on this post by email or on the web |
|
|
|
|
|
|
Photo Courtesy: Markku Toryalai Hart
|
|
|
TechNet21 is generously supported by the Bill and Melinda Gates Foundation, under the oversight of WHO and UNICEF. The information in this forum is provided by users, as a service. All contributions are reviewed prior to posting, and all postings are attributed to the authors. The details given in emails will not be voluntarily shared or sold to any outside company and will only be used for verification and to identify postings, if necessary. The authors are solely responsible for their submissions, and the readers are solely responsible for the interpretation of these submissions. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to this forum.
For posts where the author is a WHO staff member, the author alone is reponsible for the views expressed and they do not necessarily represent the decisions, guidelines, recommendations or policies of WHO.
|
|
